Julien Biolley heads up the Marketing and Business Development activities for Chr. Hansen’s Food Cultures & Enzymes in North America. Chr. Hansen is a bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries. A C25 company based in Denmark, for over 145 years the company has strived to enable sustainable agriculture, cleaner labels, and healthier living for more people around the world. Chr. Hansen’s product innovation is based on their microbial platform, which consists of about 40,000 microbial strains or what they call “good bacteria.” They produce more than 400 different bacterial strains each year and in their 2025 strategy, have committed 75% of the R&D spending to new product development. Their microbial and fermentation platforms have the potential to respond to global challenges such as food waste, global health, and the overuse of antibiotics and pesticides, and they are increasingly looking to work with startups to meet these challenges. In this episode, we discuss their 2025 strategy, how they are partnering with different stakeholders in the food ecosystem from Noma’s former Head of Fermentation David Zilber to startup accelerator programs, and the many potential applications and innovations surrounding microbes and fermentation.
- 3:10 What is good bacteria?
- 13:00 How do startup partnerships happen?
- 20:30 What is your 2025 strategy?
- 28:00 How do you do new product development?
- 40:00 How does Chr. Hansen define sustainability?
For more conversations, join our community on Instagram or check out other episodes on www.nordicfoodtech.io. Your host, Analisa Winther, would also love to connect on LinkedIn! Feedback, thoughts, and key takeaways are always welcome!